IFN-GAMMA Quantitative Test in UAE | 900 AED | DHA Licensed Laboratory

Executive Summary & Core Metrics

The IFN-GAMMA Quantitative Test delivers precise measurement of interferon-gamma levels using qPCR and whole genome sequencing across whole blood, serum, and CSF matrices. With 99.9% diagnostic sensitivity verified under ISO 9001:2015, results are reported within 24–36 hours. Every report includes a complimentary telephone consultation with a licensed UAE general practitioner. Insurance verification is available via WhatsApp at +971 54 548 8731. Hospital extraction is strictly required for CSF specimens; mobile phlebotomy is disabled for safety.

Test Overview & Methodology

This quantitative assay measures interferon-gamma, a critical cytokine released during viral infections and immune activation. The laboratory uses real-time PCR combined with whole genome sequencing to achieve unparalleled analytical sensitivity. The test supports three distinct sample matrices, each handled under strict cold-chain protocols to preserve biomolecular integrity.

Feature	IFN-GAMMA Quantitative Test	Standard ELISA-Based IGRA
Methodology	qPCR + Whole Genome Sequencing (WGS)	Enzyme-Linked Immunosorbent Assay
Diagnostic Sensitivity	99.9% (ISO-verified)	~95%
Turnaround Time	24–36 hours	48–72 hours
Sample Types	Whole Blood, Serum, CSF	Whole Blood only
Pathogen Coverage	Broad viral & genetic susceptibility markers	Primarily M. tuberculosis

Physician Insight & Safety Protocols

“Interferon-gamma levels must always be interpreted within the full clinical context and cannot replace a thorough physical examination. An elevated result may reflect recent viral exposure, latent tuberculosis, or immune reconstitution syndrome. Correlation with patient history, imaging, and additional laboratory markers is essential before drawing any therapeutic conclusions.”

— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132

⚠️ Medication Advisory

Do not discontinue any prescribed medication, including antivirals or immunosuppressants, without explicit consultation with your treating physician. Test results provide laboratory evidence and must never replace professional medical judgment or override prescribed therapy.

Exclusion Criteria & ER Red Flags

Severe bleeding disorders (e.g., hemophilia) not cleared by a specialist prior to collection.
Active chemotherapy or radiotherapy without documented oncologist clearance.
Known allergy to phlebotomy materials, antiseptics, or latex used during sample collection.
Inability to provide informed consent or lack of a legally authorized representative.

Seek emergency care immediately if you experience: severe dizziness, fainting, rapidly spreading redness, or fever after sample collection.

Patient FAQ & Clinical Guidance

1. What does the IFN-Gamma Quantitative test diagnose?

This test quantifies interferon-gamma, a key cytokine that helps detect active viral infections and immune system dysregulation. It aids in identifying immune responses against pathogens such as cytomegalovirus, Epstein-Barr virus, or SARS-CoV-2, and can indicate latent tuberculosis when combined with specific antigens. The result is not a standalone diagnosis; your doctor will integrate it with symptoms, imaging, and other lab markers for a definitive clinical picture.

2. How should I prepare for sample collection?

Fasting is not required, but staying well-hydrated and wearing loose clothing facilitates venous access. Bring your Emirates ID, insurance card, and any relevant medical reports. For whole blood or serum draws, our mobile phlebotomist will review and sign a consent form before collecting the sample into a temperature-controlled cold-chain container. If a CSF specimen is ordered, collection must be performed inside an accredited hospital facility by a qualified specialist. Avoid heavy exercise for 24 hours prior, as it may transiently alter cytokine levels.

3. What does a positive result mean for my treatment plan?

A positive result indicates elevated interferon-gamma, which may stem from an ongoing viral infection or robust immune activation. Your physician will typically order supplementary tests—such as viral PCR panels, imaging, or biopsy—to determine the precise cause. Treatment may include antiviral agents, immunomodulators, or watchful waiting depending on the final diagnosis. Never self-medicate or alter your medication regimen based solely on this laboratory value.

4. How long does it take to receive my results?

Results are typically available within 24 to 36 hours after the sample reaches our laboratory. Once finalized, you will receive a secure digital report via email or WhatsApp, followed by a complimentary telephone consultation with a licensed general practitioner to discuss the findings and next steps.

5. Is the test covered by my health insurance in the UAE?

Coverage depends on your specific policy and insurer. We provide instant verification via WhatsApp—send your policy details to +971 54 548 8731 and receive confirmation within minutes. Major UAE networks accepted include Daman, ADNIC, Neuron, and many others.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates under the governance of the Dubai Health Authority (DHA) and adheres to all applicable UAE federal laws. Patient data is protected in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing, patient safety protocols, and informed consent procedures follow the standards set forth in Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is fully licensed by DHA and MOHAP.

Clinical & Logistical Metadata

Test Name	IFN-GAMMA Quantitative Test
Price (AED)	900
Turnaround Time	24–36 hours
Sample Type / Matrix	Whole Blood, Serum, CSF (CSF collection strictly requires hospital extraction)
Methodology Used	qPCR + Whole Genome Sequencing (WGS)
ICD-10-CM Code	R79.89
LOINC Code	71647-9
DHA Facility License & Address	License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE